LONDON - Cell Medica Ltd. has treated the first patient in a Phase III trial of a cell therapy treatment for the prevention of cytomegalovirus (CMV) infection in immunocompromised bone marrow transplant patients. (BioWorld International)

No AbstractPARIS - Hybrigenics SA has been granted a refundable subsidy of €1.4 million (US$2 million) by France's state agency for promoting innovation and supporting small and medium-sized enterprises, OSEO, to finance the development of inecalcitol as a treatment for prostate cancer.

LONDON - Anglo/German kinase specialist Cellzome Inc., sealed a deal worth a headline value of £830 million (US$1.5 billion) with GlaxoSmithKline plc for the development of kinase inhibitors in the treatment of inflammatory diseases. (BioWorld International)